Home
About NCCTG
About Clinical Trials
NCCTG Trial Listings
Treatment Trials
Prevention/ Symptom Management Trials
Treating Locations
NCCTG News
Patient Advocacy
Biospecimen Access
Links
System
Institutional Members Only

Esophagus

The following NCCTG cancer treatment clinical trials are currently active. You may click on the trial number to link to a detailed description on PDQ, the National Cancer Institute's Web site for clinical trials.
N0747 A Randomized Phase II Trial of Sunitinib Plus Capecitabine Versus Capecitabine Alone (with the potential for crossover) for Elderly and/or Poor Performance Status Patients with Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction
N0849 Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, or Gastric Cardia

For more information, please discuss these trials with your physician, contact the NCCTG Operations Office or contact an NCCTG treating location near you.


Return to list of Cancer Treatment Trials



© Copyright 2010, NCCTG